Meeting
2023 ASCO Quality Care Symposium
Pilot trial of an educational immunotherapy intervention for patients with advanced cancer.
Authors
Laura A Petrillo
Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston, MA
Laura A Petrillo, Kelly Hsu, Kedie Pintro, Dustin Rabideau, Ashley Zhou, Ryan J. Sullivan, Kerry Lynn Reynolds, Areej El-Jawahri, Angelo E. Volandes, Joseph A. Greer, Jennifer S. Temel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Communication and Shared Decision-Making Research
Clinical Trial Registration Number
NCT04670445
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 307)
DOI
10.1200/OP.2023.19.11_suppl.307
Abstract #
307
Poster Bd #
C30
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Gut microbiome to predict efficacy and immune-related toxicities in patients with advanced non-small cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy.
First Author: Taiki Hakozaki
Poster
2024 ASCO Genitourinary Cancers Symposium
The feasibility of an educational and monitoring smartphone application for patients with advanced renal cell carcinoma undergoing combination immunotherapy.
First Author: Gabriel Roman Souza
Poster
2023 ASCO Breakthrough
Efficacy of PD-1 inhibitors in the treatment of advanced gastrointestinal tumors and the effect on T-lymphocyte subsets and IL-6 levels in patients.
First Author: XinCheng He
Poster
2023 ASCO Annual Meeting
Phase II study of lenvatinib plus pembrolizumab for patients with immunotherapy-naive advanced gastric cancer following first line therapy.
First Author: Deirdre Jill Cohen